Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Non-Current Assets (2021 - 2025)

Rxo's Non-Current Assets history spans 5 years, with the latest figure at $2.0 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 5.54% year-over-year to $2.0 billion; the TTM value through Dec 2025 reached $2.0 billion, down 5.54%, while the annual FY2025 figure was $2.0 billion, 5.54% down from the prior year.
  • Non-Current Assets reached $2.0 billion in Q4 2025 per RXO's latest filing, down from $2.0 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $2.1 billion in Q3 2024 to a low of $985.0 million in Q4 2021.
  • Average Non-Current Assets over 5 years is $1.4 billion, with a median of $1.0 billion recorded in 2023.
  • Peak YoY movement for Non-Current Assets: soared 111.58% in 2024, then fell 6.41% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $985.0 million in 2021, then rose by 1.73% to $1.0 billion in 2022, then grew by 2.69% to $1.0 billion in 2023, then surged by 101.65% to $2.1 billion in 2024, then decreased by 5.54% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for RXO's Non-Current Assets are $2.0 billion (Q4 2025), $2.0 billion (Q3 2025), and $2.0 billion (Q2 2025).